Cargando…

Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020

Among 582 participants in Western Kenya who were retrospectively tested from January through March 2020, 19 (3.3%) had detectable SARS-CoV-2 antibodies. The prevalence of detectable SARS-CoV-2 antibodies was similar between participants with and without HIV (3.1% vs. 4%, P = 0.68). One participant r...

Descripción completa

Detalles Bibliográficos
Autores principales: Crowell, Trevor A., Daud, Ibrahim I., Maswai, Jonah, Owuoth, John, Sing’oei, Valentine, Imbach, Michelle, Dear, Nicole, Sawe, Fred, Eller, Leigh Anne, Polyak, Christina S., Ake, Julie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631158/
https://www.ncbi.nlm.nih.gov/pubmed/34482354
http://dx.doi.org/10.1097/QAD.0000000000003054
_version_ 1784607497513861120
author Crowell, Trevor A.
Daud, Ibrahim I.
Maswai, Jonah
Owuoth, John
Sing’oei, Valentine
Imbach, Michelle
Dear, Nicole
Sawe, Fred
Eller, Leigh Anne
Polyak, Christina S.
Ake, Julie A.
author_facet Crowell, Trevor A.
Daud, Ibrahim I.
Maswai, Jonah
Owuoth, John
Sing’oei, Valentine
Imbach, Michelle
Dear, Nicole
Sawe, Fred
Eller, Leigh Anne
Polyak, Christina S.
Ake, Julie A.
author_sort Crowell, Trevor A.
collection PubMed
description Among 582 participants in Western Kenya who were retrospectively tested from January through March 2020, 19 (3.3%) had detectable SARS-CoV-2 antibodies. The prevalence of detectable SARS-CoV-2 antibodies was similar between participants with and without HIV (3.1% vs. 4%, P = 0.68). One participant reported a cough in the preceding week but others denied symptoms. These may represent cross-reactivity or asymptomatic infections that predated the first reported COVID-19 cases in Kenya.
format Online
Article
Text
id pubmed-8631158
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86311582021-12-07 Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020 Crowell, Trevor A. Daud, Ibrahim I. Maswai, Jonah Owuoth, John Sing’oei, Valentine Imbach, Michelle Dear, Nicole Sawe, Fred Eller, Leigh Anne Polyak, Christina S. Ake, Julie A. AIDS Research Letters Among 582 participants in Western Kenya who were retrospectively tested from January through March 2020, 19 (3.3%) had detectable SARS-CoV-2 antibodies. The prevalence of detectable SARS-CoV-2 antibodies was similar between participants with and without HIV (3.1% vs. 4%, P = 0.68). One participant reported a cough in the preceding week but others denied symptoms. These may represent cross-reactivity or asymptomatic infections that predated the first reported COVID-19 cases in Kenya. Lippincott Williams & Wilkins 2021-11-15 2021-09-03 /pmc/articles/PMC8631158/ /pubmed/34482354 http://dx.doi.org/10.1097/QAD.0000000000003054 Text en Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.
spellingShingle Research Letters
Crowell, Trevor A.
Daud, Ibrahim I.
Maswai, Jonah
Owuoth, John
Sing’oei, Valentine
Imbach, Michelle
Dear, Nicole
Sawe, Fred
Eller, Leigh Anne
Polyak, Christina S.
Ake, Julie A.
Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020
title Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020
title_full Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020
title_fullStr Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020
title_full_unstemmed Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020
title_short Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020
title_sort severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without hiv in rural western kenya, january to march 2020
topic Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631158/
https://www.ncbi.nlm.nih.gov/pubmed/34482354
http://dx.doi.org/10.1097/QAD.0000000000003054
work_keys_str_mv AT crowelltrevora severeacuterespiratorysyndromecoronavirus2antibodyprevalenceinpeoplewithandwithouthivinruralwesternkenyajanuarytomarch2020
AT daudibrahimi severeacuterespiratorysyndromecoronavirus2antibodyprevalenceinpeoplewithandwithouthivinruralwesternkenyajanuarytomarch2020
AT maswaijonah severeacuterespiratorysyndromecoronavirus2antibodyprevalenceinpeoplewithandwithouthivinruralwesternkenyajanuarytomarch2020
AT owuothjohn severeacuterespiratorysyndromecoronavirus2antibodyprevalenceinpeoplewithandwithouthivinruralwesternkenyajanuarytomarch2020
AT singoeivalentine severeacuterespiratorysyndromecoronavirus2antibodyprevalenceinpeoplewithandwithouthivinruralwesternkenyajanuarytomarch2020
AT imbachmichelle severeacuterespiratorysyndromecoronavirus2antibodyprevalenceinpeoplewithandwithouthivinruralwesternkenyajanuarytomarch2020
AT dearnicole severeacuterespiratorysyndromecoronavirus2antibodyprevalenceinpeoplewithandwithouthivinruralwesternkenyajanuarytomarch2020
AT sawefred severeacuterespiratorysyndromecoronavirus2antibodyprevalenceinpeoplewithandwithouthivinruralwesternkenyajanuarytomarch2020
AT ellerleighanne severeacuterespiratorysyndromecoronavirus2antibodyprevalenceinpeoplewithandwithouthivinruralwesternkenyajanuarytomarch2020
AT polyakchristinas severeacuterespiratorysyndromecoronavirus2antibodyprevalenceinpeoplewithandwithouthivinruralwesternkenyajanuarytomarch2020
AT akejuliea severeacuterespiratorysyndromecoronavirus2antibodyprevalenceinpeoplewithandwithouthivinruralwesternkenyajanuarytomarch2020